HOME › DRUGS › COPANLISIB
ACTIVE SUBSTANCE / INN

COPANLISIB

Brand name(s): Aliqopa
EMA LISTED
APPLICATION WITHDRAWN
Lymphoma, B-Cell, Marginal Zone
ACTIVE SUBSTANCE
Copanlisib
REGULATORS
EMA
SPONSORS / MAH
Bayer AG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AliqopaBayer AGApplication withdrawnLymphoma, B-Cell, Marginal Zone

FULL INTELLIGENCE ON COPANLISIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →